At TESARO, relationships are vital to the success of our business, and we are committed to being a trusted partner to the oncology community and the people it serves.
The TESARO team has a track record of success in identifying, acquiring, developing, and commercializing oncology therapeutics that make a meaningful difference in the lives of people with unmet clinical needs. The alliances we select enable us to focus our resources and energies on discovering therapies that make a difference in the lives of people living with cancer.
TESARO supports educational grants related to therapeutic areas in which we have approved or investigational assets for the education of healthcare providers, patients, and care partners.
Our translational research program focuses on understanding mechanisms of action of our compounds, identifying patients most likely to benefit from treatment, and informing new combination strategies for patients living with cancer.
This program is open to all researchers who are interested in conducting their own clinical research. External investigators can collaborate with R&D experts at TESARO to develop clinical studies and may receive compound and/or funding to support independent research activities.